NATIVE AMERICAN CANCER RESEARCH has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN
| Measure | Date | Value |
|---|
| 2022 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2022 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total income from all sources (including contributions) | 2022-12-31 | $-2,537 |
| Total loss/gain on sale of assets | 2022-12-31 | $0 |
| Total of all expenses incurred | 2022-12-31 | $43 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $0 |
| Value of total assets at end of year | 2022-12-31 | $0 |
| Value of total assets at beginning of year | 2022-12-31 | $23,354 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $43 |
| Total interest from all sources | 2022-12-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $0 |
| Administrative expenses professional fees incurred | 2022-12-31 | $43 |
| Total non interest bearing cash at end of year | 2022-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2022-12-31 | $0 |
| Value of net income/loss | 2022-12-31 | $-2,580 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $0 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $23,354 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $23,354 |
| Net investment gain/loss from pooled separate accounts | 2022-12-31 | $-2,537 |
| Total unrealized appreciation/depreciation of assets | 2022-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total income from all sources (including contributions) | 2022-01-01 | $-2,537 |
| Total loss/gain on sale of assets | 2022-01-01 | $0 |
| Total of all expenses incurred | 2022-01-01 | $43 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-01-01 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-01-01 | $0 |
| Value of total assets at end of year | 2022-01-01 | $0 |
| Value of total assets at beginning of year | 2022-01-01 | $23,354 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-01-01 | $43 |
| Total interest from all sources | 2022-01-01 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-01-01 | $0 |
| Administrative expenses professional fees incurred | 2022-01-01 | $43 |
| Total non interest bearing cash at end of year | 2022-01-01 | $0 |
| Total non interest bearing cash at beginning of year | 2022-01-01 | $0 |
| Value of net income/loss | 2022-01-01 | $-2,580 |
| Value of net assets at end of year (total assets less liabilities) | 2022-01-01 | $0 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-01-01 | $23,354 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-01-01 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-01-01 | $23,354 |
| Net investment gain/loss from pooled separate accounts | 2022-01-01 | $-2,537 |
| 2021 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2021 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total income from all sources (including contributions) | 2021-12-31 | $3,573 |
| Total loss/gain on sale of assets | 2021-12-31 | $0 |
| Total of all expenses incurred | 2021-12-31 | $12,251 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $11,875 |
| Expenses. Certain deemed distributions of participant loans | 2021-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $0 |
| Value of total assets at end of year | 2021-12-31 | $23,354 |
| Value of total assets at beginning of year | 2021-12-31 | $31,757 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $376 |
| Total interest from all sources | 2021-12-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $0 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
| Administrative expenses professional fees incurred | 2021-12-31 | $103 |
| Was this plan covered by a fidelity bond | 2021-12-31 | No |
| If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
| Contributions received from participants | 2021-12-31 | $0 |
| Participant contributions at end of year | 2021-12-31 | $0 |
| Participant contributions at beginning of year | 2021-12-31 | $0 |
| Participant contributions at beginning of year | 2021-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2021-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2021-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $0 |
| Total non interest bearing cash at end of year | 2021-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2021-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Value of net income/loss | 2021-12-31 | $-8,678 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $23,354 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $31,757 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $23,354 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $31,757 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2021-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2021-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $3,573 |
| Net investment gain/loss from pooled separate accounts | 2021-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
| Contributions received in cash from employer | 2021-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2021-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $11,875 |
| Contract administrator fees | 2021-12-31 | $273 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2021-12-31 | No |
| Liabilities. Value of benefit claims payable at end of year | 2021-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2021-12-31 | $0 |
| Did the plan have assets held for investment | 2021-12-31 | No |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
| 2020 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2020 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total income from all sources (including contributions) | 2020-12-31 | $0 |
| Total loss/gain on sale of assets | 2020-12-31 | $0 |
| Total of all expenses incurred | 2020-12-31 | $568 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $0 |
| Value of total assets at end of year | 2020-12-31 | $0 |
| Value of total assets at beginning of year | 2020-12-31 | $28,237 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $568 |
| Total interest from all sources | 2020-12-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $0 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
| Administrative expenses professional fees incurred | 2020-12-31 | $101 |
| Was this plan covered by a fidelity bond | 2020-12-31 | No |
| If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
| Contributions received from participants | 2020-12-31 | $0 |
| Participant contributions at beginning of year | 2020-12-31 | $0 |
| Participant contributions at beginning of year | 2020-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2020-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2020-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Income. Non cash contributions | 2020-12-31 | $0 |
| Value of net income/loss | 2020-12-31 | $-568 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $0 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $28,237 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $31,757 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $28,171 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $66 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
| Assets. Invements in employer securities at beginning of year | 2020-12-31 | $0 |
| Contributions received in cash from employer | 2020-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2020-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $0 |
| Contract administrator fees | 2020-12-31 | $467 |
| Liabilities. Value of benefit claims payable at end of year | 2020-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2020-12-31 | $0 |
| Did the plan have assets held for investment | 2020-12-31 | No |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
| 2019 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2019 401k financial data |
|---|
| Total plan liabilities at beginning of year | 2019-12-31 | $0 |
| Total income from all sources | 2019-12-31 | $5,058 |
| Expenses. Total of all expenses incurred | 2019-12-31 | $2,691 |
| Benefits paid (including direct rollovers) | 2019-12-31 | $2,491 |
| Total plan assets at end of year | 2019-12-31 | $28,171 |
| Total plan assets at beginning of year | 2019-12-31 | $25,805 |
| Other income received | 2019-12-31 | $5,058 |
| Net income (gross income less expenses) | 2019-12-31 | $2,367 |
| Net plan assets at end of year (total assets less liabilities) | 2019-12-31 | $28,171 |
| Net plan assets at beginning of year (total assets less liabilities) | 2019-12-31 | $25,805 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2019-12-31 | $200 |
| 2018 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2018 401k financial data |
|---|
| Total plan liabilities at beginning of year | 2018-12-31 | $0 |
| Total income from all sources | 2018-12-31 | $3,701 |
| Expenses. Total of all expenses incurred | 2018-12-31 | $11,537 |
| Benefits paid (including direct rollovers) | 2018-12-31 | $8,500 |
| Total plan assets at end of year | 2018-12-31 | $25,805 |
| Total plan assets at beginning of year | 2018-12-31 | $33,052 |
| Expenses. Other expenses not covered elsewhere | 2018-12-31 | $2,281 |
| Other income received | 2018-12-31 | $1 |
| Net income (gross income less expenses) | 2018-12-31 | $-7,836 |
| Net plan assets at end of year (total assets less liabilities) | 2018-12-31 | $25,805 |
| Net plan assets at beginning of year (total assets less liabilities) | 2018-12-31 | $33,052 |
| Total contributions received or receivable from employer(s) | 2018-12-31 | $3,700 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2018-12-31 | $756 |
| 2015 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2015 401k financial data |
|---|
| Total income from all sources | 2015-12-31 | $1,408 |
| Expenses. Total of all expenses incurred | 2015-12-31 | $5,131 |
| Benefits paid (including direct rollovers) | 2015-12-31 | $5,000 |
| Total plan assets at end of year | 2015-12-31 | $88,063 |
| Total plan assets at beginning of year | 2015-12-31 | $91,786 |
| Total contributions received or receivable from participants | 2015-12-31 | $2,600 |
| Other income received | 2015-12-31 | $-1,844 |
| Net income (gross income less expenses) | 2015-12-31 | $-3,723 |
| Net plan assets at end of year (total assets less liabilities) | 2015-12-31 | $88,063 |
| Net plan assets at beginning of year (total assets less liabilities) | 2015-12-31 | $91,786 |
| Total contributions received or receivable from employer(s) | 2015-12-31 | $652 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2015-12-31 | $131 |
| 2014 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2014 401k financial data |
|---|
| Transfers to/from the plan | 2014-12-31 | $-19,365 |
| Total income from all sources | 2014-12-31 | $2,679 |
| Expenses. Total of all expenses incurred | 2014-12-31 | $1,745 |
| Benefits paid (including direct rollovers) | 2014-12-31 | $1,591 |
| Total plan assets at end of year | 2014-12-31 | $91,786 |
| Total plan assets at beginning of year | 2014-12-31 | $110,217 |
| Total contributions received or receivable from participants | 2014-12-31 | $4,350 |
| Other income received | 2014-12-31 | $-5,889 |
| Net income (gross income less expenses) | 2014-12-31 | $934 |
| Net plan assets at end of year (total assets less liabilities) | 2014-12-31 | $91,786 |
| Net plan assets at beginning of year (total assets less liabilities) | 2014-12-31 | $110,217 |
| Total contributions received or receivable from employer(s) | 2014-12-31 | $4,218 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2014-12-31 | $154 |
| 2013 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2013 401k financial data |
|---|
| Total income from all sources | 2013-12-31 | $31,821 |
| Expenses. Total of all expenses incurred | 2013-12-31 | $5,656 |
| Benefits paid (including direct rollovers) | 2013-12-31 | $5,467 |
| Total plan assets at end of year | 2013-12-31 | $110,217 |
| Total plan assets at beginning of year | 2013-12-31 | $84,052 |
| Total contributions received or receivable from participants | 2013-12-31 | $5,163 |
| Other income received | 2013-12-31 | $21,495 |
| Net income (gross income less expenses) | 2013-12-31 | $26,165 |
| Net plan assets at end of year (total assets less liabilities) | 2013-12-31 | $110,217 |
| Net plan assets at beginning of year (total assets less liabilities) | 2013-12-31 | $84,052 |
| Total contributions received or receivable from employer(s) | 2013-12-31 | $5,163 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2013-12-31 | $189 |
| 2012 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2012 401k financial data |
|---|
| Total income from all sources | 2012-12-31 | $26,994 |
| Expenses. Total of all expenses incurred | 2012-12-31 | $28,101 |
| Benefits paid (including direct rollovers) | 2012-12-31 | $26,261 |
| Total plan assets at end of year | 2012-12-31 | $84,052 |
| Total plan assets at beginning of year | 2012-12-31 | $85,159 |
| Total contributions received or receivable from participants | 2012-12-31 | $8,956 |
| Expenses. Other expenses not covered elsewhere | 2012-12-31 | $1,499 |
| Other income received | 2012-12-31 | $9,082 |
| Net income (gross income less expenses) | 2012-12-31 | $-1,107 |
| Net plan assets at end of year (total assets less liabilities) | 2012-12-31 | $84,052 |
| Net plan assets at beginning of year (total assets less liabilities) | 2012-12-31 | $85,159 |
| Total contributions received or receivable from employer(s) | 2012-12-31 | $8,956 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2012-12-31 | $341 |
| 2011 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2011 401k financial data |
|---|
| Total income from all sources | 2011-12-31 | $15,210 |
| Expenses. Total of all expenses incurred | 2011-12-31 | $12,233 |
| Benefits paid (including direct rollovers) | 2011-12-31 | $11,321 |
| Total plan assets at end of year | 2011-12-31 | $85,159 |
| Total plan assets at beginning of year | 2011-12-31 | $82,182 |
| Total contributions received or receivable from participants | 2011-12-31 | $9,315 |
| Expenses. Other expenses not covered elsewhere | 2011-12-31 | $612 |
| Other income received | 2011-12-31 | $-3,420 |
| Net income (gross income less expenses) | 2011-12-31 | $2,977 |
| Net plan assets at end of year (total assets less liabilities) | 2011-12-31 | $85,159 |
| Net plan assets at beginning of year (total assets less liabilities) | 2011-12-31 | $82,182 |
| Total contributions received or receivable from employer(s) | 2011-12-31 | $9,315 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2011-12-31 | $300 |
| 2010 : NATIVE AMERICAN CANCER RESEARCH CORP. 403(B) PLAN 2010 401k financial data |
|---|
| Total income from all sources | 2010-12-31 | $25,755 |
| Expenses. Total of all expenses incurred | 2010-12-31 | $12,794 |
| Benefits paid (including direct rollovers) | 2010-12-31 | $12,178 |
| Total plan assets at end of year | 2010-12-31 | $77,078 |
| Total plan assets at beginning of year | 2010-12-31 | $64,117 |
| Total contributions received or receivable from participants | 2010-12-31 | $9,100 |
| Expenses. Other expenses not covered elsewhere | 2010-12-31 | $324 |
| Other income received | 2010-12-31 | $7,555 |
| Net income (gross income less expenses) | 2010-12-31 | $12,961 |
| Net plan assets at end of year (total assets less liabilities) | 2010-12-31 | $77,078 |
| Net plan assets at beginning of year (total assets less liabilities) | 2010-12-31 | $64,117 |
| Total contributions received or receivable from employer(s) | 2010-12-31 | $9,100 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2010-12-31 | $292 |
